On DIPG Awareness Day, which takes place each year on 17th May, we’re sharing what Brain Tumour Research is doing to find a cure for this deadly type of tumour.
Diffuse intrinsic pontine glioma (DIPG) – also known as brainstem glioma and most recently renamed diffuse midline glioma – is an aggressive, high-grade brain tumour, most often occurring in children.
This type of tumour:
- Is the leading cause of brain tumour deaths in children
- Has an extremely poor prognosis of eight to 12 months
- Is incredibly difficult to treat due to its location in the pons/brainstem and diffuse nature
In a blog published today, Rebecca Rogers, a postdoctoral Research Fellow at our newly-announced Centre of Excellence at The Institute of Cancer Research (ICR), shares more about this tumour type including why it is so difficult to treat.
Rebecca explains more about her work which focuses on paediatric high-grade gliomas, including DIPG, what a typical day in the lab looks like, and why she feels “privileged” to be researching this devastating disease.
To read our interview with Rebecca, click here:
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.